Nystatin
Rank #411 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$21.4M
Total Cost
908,177
Total Claims
$21.4M
Total Cost
38,472
Prescribers
$24
Cost per Claim
323,054
Beneficiaries
950,839
30-Day Fills
$555
Avg Cost/Provider
24
Avg Claims/Provider
Share of Medicare Part D Spending
0.01%
of total Medicare Part D spending
$21.4M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $21.4M total
Top Prescribers of Nystatin
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Lan Su | Dentist | Westlake Village, CA | 346 | $31K |
| 2 | Charles Crist | Family Practice | Ashland, MO | 143 | $20K |
| 3 | Clemencia Rasquinha | Geriatric Medicine | Golden Valley, MN | 458 | $13K |
| 4 | Matthew Britt | Podiatry | Rockwall, TX | 99 | $13K |
| 5 | Sandra Denton | Family Practice | Anchorage, AK | 96 | $12K |
| 6 | James Ziobron | Family Practice | Bruce, MI | 182 | $12K |
| 7 | Syed Hashmi | Internal Medicine | Sikeston, MO | 248 | $12K |
| 8 | John Fallon | Nurse Practitioner | Hyde Park, NY | 147 | $11K |
| 9 | Brittney Andersen | Nurse Practitioner | Draper, UT | 523 | $11K |
| 10 | Juan Rocha | Podiatry | Brownsville, TX | 708 | $11K |
| 11 | Rajesh Agarwal | Internal Medicine | Mayfield Heights, OH | 452 | $11K |
| 12 | Sheryl Pearl | Family Practice | Brooklyn, NY | 403 | $8,942 |
| 13 | Jerry Cioffi | Oral Surgery (Dentist only) | Orange Park, FL | 788 | $8,625 |
| 14 | Andrew Graf | Internal Medicine | Plymouth Meeting, PA | 326 | $8,556 |
| 15 | David Pawlowski | Family Practice | Williamsville, NY | 309 | $8,376 |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 408 | Asciminib Hydrochloride (Scemblix) | $21.4M | 830 |
| 409 | Cephalexin (Cephalexin) | $21.4M | 2,407,718 |
| 410 | Teprotumumab-Trbw (Tepezza) | $21.4M | 389 |
| 411 | Nystatin (Nystatin) | $21.4M | 908,177 |
| 412 | Desvenlafaxine Succinate (Desvenlafaxine Succinate Er) | $21.3M | 257,580 |
| 413 | Sotorasib (Lumakras) | $21.3M | 1,188 |
| 414 | Ibuprofen (Ibuprofen) | $21.2M | 2,537,634 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology